PetMed Express, Inc. : PETMED EXPRESS D/B/A 1-800-PETMEDS TO ANNOUNCE ITS THIRD QUARTER FINANCIAL RESULTS ON JANUARY 23, 2012
January 18, 2012 at 10:19 am
By
Share
PetMeds®Press Releases
01.17.2012
Pompano Beach, Florida, January 17, 2012 - PetMed Express,
Inc. (NASDAQ: PETS) will announce its financial results for
the quarter ended December 31, 2011 on Monday, January 23,
2012 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern
Time, Menderes Akdag, the Company's Chief Executive Officer
and President, will host a conference call to review the
financial results.
To access the call, which is open to the public, please dial
(888) 455-1758 (toll free) or (210) 234-0009, ten minutes
prior to the scheduled start time. Callers will be required
to supply PETMEDS as the passcode, and will be placed on hold
with music until the call begins.
For those unable to participate in the live event, the call
will be available for replay from 10:00 A.M. Eastern Time on
January 23, 2012 until February 6, 2012 at 10:59 P.M. Eastern
Time. To access the replay, call (888) 562-3875 (toll free)
or (203) 369-3173, and enter passcode 5500.
Founded in 1996, PetMed Express is America's Largest Pet
Pharmacy, delivering prescription and non-prescription pet
medications and other health products for dogs and cats, at
competitive prices direct to the consumer through its
1-800-PetMeds toll free number and on the Internet through
its website at .
This press release may contain "forward-looking" statements,
as defined in the Private Securities Litigation Reform Act of
1995 or by the Securities and Exchange Commission, that
involve a number of risks and uncertainties, including the
Company's ability to meet the objectives included in its
business plan. Important factors that could cause results to
differ materially from those indicated by such
"forward-looking" statements are set forth in Management's
Discussion and Analysis of Financial Condition and Results of
Operations in the PetMed Express Annual Report on Form 10-K
for the year ended March 31, 2011. The Company's future
results may also be impacted by other risk factors listed
from time to time in its SEC filings, including, but not
limited to, the Company's Form 10-Q and its Annual Report
on Form 10-K.
For investment relations contact PetMed Express, Inc., Bruce
S. Rosenbloom, CFO, 954-979-5995.
###
distribué par
Ce noodl a été diffusé par PetMed Express Inc. et initialement mise en ligne sur le site http://www.1800petmeds.com. La version originale est disponible ici.
Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-18 15:59:22 PM et restera accessible depuis ce lien permanent.
Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.